Actively Recruiting

Phase Not Applicable
Age: 6Years - 18Years
All Genders
NCT05555771

Paediatric Syncope in the Emergency Department

Led by Dr. Victoria Claydon · Updated on 2026-04-23

300

Participants Needed

1

Research Sites

264 weeks

Total Duration

On this page

Sponsors

D

Dr. Victoria Claydon

Lead Sponsor

P

Provincial Health Services Authority British Columbia

Collaborating Sponsor

AI-Summary

What this Trial Is About

The investigators will assess the efficacy of clinically recommended counterpressure maneuvers (CPM) in preventing syncope for paediatric patients. Participants presenting to the emergency department (ED) will first provide written informed consent. In stage I, they will be asked to complete a brief survey documenting the presentation of their syncopal episode, and any prodromal symptoms they experienced. Participants that consent to the second stage of the study will either receive usual care (control arm) or training in counter pressure maneuvers alongside usual care (intervention arm; leg crossing, bending, arm tensing). These patients will be followed for one years time, and will be asked to complete monthly surveys detailing their syncopal and presyncopal recurrence. Medical records will be accessed over the duration of the study to identify any changes in medical diagnosis.

CONDITIONS

Official Title

Paediatric Syncope in the Emergency Department

Who Can Participate

Age: 6Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Between 6 and 18 years old (inclusive)
  • Presenting to the emergency department daily from 10:00 to 22:00 with resolved transient loss of consciousness within the last week
  • Able to complete the survey in English
  • Willing and able to provide consent and assent
Not Eligible

You will not qualify if you...

  • Known or suspected cardiac arrhythmia diagnosis (e.g., Wolff-Parkinson-White, long QT)
  • Traumatic head injury
  • New presentation of seizure disorder
  • Epilepsy recurrence
  • Overdose or intoxication
  • Structural heart disease
  • Hypoglycemia
  • Psychogenic vasovagal syncope without prodromal symptoms
  • Previously enrolled in this study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

BC Children's Hospital

Vancouver, British Columbia, Canada, V6H3N1

Actively Recruiting

Loading map...

Research Team

E

Erin L Williams, BSc

CONTACT

S

Sonia Franciosi, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here